ABIO insider transaction filings
ARCA biopharma, Inc. — 4 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-08-30. Screen ABIO transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ABIO between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — ARCA biopharma, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-08-30 | 4 | Ma-Weaver Jacob | Other (J): 6,000 (derivative) · Other (J): 6,000 (derivative) · Other (J): 12,000 (derivative) | EDGAR |
| 2024-08-20 | 4 | JANUS HENDERSON GROUP PLC — 10% owner Janus Henderson Biotech Innovation Master Fund Ltd — 10% owner | Purchase (P): 5,390 @ $2.93 · Purchase (P): 428 @ $2.98 | EDGAR |
| 2024-07-26 | 4 | JANUS HENDERSON GROUP PLC — 10% owner Janus Henderson Biotech Innovation Master Fund Ltd — 10% owner | Purchase (P): 165,000 @ $3.20 · Purchase (P): 17,800 @ $3.18 · Purchase (P): 7,056 @ $3.16 · Purchase (P): 30,227 @ $3.05 | EDGAR |
| 2024-07-12 | 4 | JANUS HENDERSON GROUP PLC — 10% owner Janus Henderson Biotech Innovation Master Fund Ltd — 10% owner | Purchase (P): 166,042 @ $3.55 · Purchase (P): 23,326 @ $3.43 · Purchase (P): 5,000 @ $3.41 · Purchase (P): 29,892 @ $3.41 · Purchase (P): 17,600 @ $3.54 · Purchase (P): 16,917 @ $3.43 · +3 more | EDGAR |
Recent 8-K events — ARCA biopharma, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-03 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ABIO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →